EXTRASKELETAL MYXOID CHONDROSARCOMA

EXTRASKELETAL MYXOID CHONDROSARCOMA was reported 11 times

EXTRASKELETAL MYXOID CHONDROSARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 3 0.0000
1 Interleukin-17A Antagonist [EPC] 1 0.0000
2 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
4 Alkylating Drug [EPC] 2 0.0000
5 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
6 Platinum-based Drug [EPC] 2 0.0000
7 Kinase Inhibitor [EPC] 3 0.0000
8 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
10 Loop Diuretic [EPC] 1 0.0000
11 Benzodiazepine [EPC] 1 0.0000
12 Corticosteroid [EPC] 1 0.0000